Plegidry

Ian Somaiya on Friday commented in a note that Biogen Idec Inc's (NASDAQ: BIIB) management team during a recent analyst meeting pointed to potential reasons for the recent slowdown in Ecfidera uptake. According to Somaiya, Biogen noted: "1) The burst of active switching caused by...